Flulaval 2026/2027 19515-0822-52
Generic: Influenza Virus Vaccine
- Manufacturer
- Id Biomedical Corporation Of Quebec
- Dosage Form
- Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- July 1, 2026
- Application
- BLA125163
Active Ingredients
| Ingredient | Strength |
|---|---|
| Influenza A Virus A/switzerland/6849/2025 Ivr 278 (h1n1) Antigen (uv, Formaldehyde Inactivated) | 15 ug/.5mL |
| Influenza A Virus A/michigan/105/2025 San 049a (h3n2) Antigen (uv, Formaldehyde Inactivated) | 15 ug/.5mL |
| Influenza B Virus B/tokyo/eis13-175/2025 Antigen (uv, Formaldehyde Inactivated) | 15 ug/.5mL |
Selected Package
19515-0822-52Selected10 SYRINGE in 1 CARTON (19515-822-52) / .5 mL in 1 SYRINGE (19515-822-41)